Heintzman, John
Bailey, Steffani R.
DeVoe, Jennifer
Cowburn, Stuart
Kapka, Tanya
Duong, Truc-Vi
Marino, Miguel
Funding for this research was provided by:
Agency for Healthcare Research and Quality (K08 HS021 522, R01HS024270)
National Institute on Drug Abuse (K23DA037453)
Article History
Received: 8 December 2015
Revised: 29 March 2016
Accepted: 31 March 2016
First Online: 22 April 2016
Compliance with Ethical Standards
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The Institutional Review Board of Oregon Health and Science University (OHSU) approved this study.
: The study received funding from the Agency for Healthcare Quality and Research (AHRQ) Grant No. K08 HS021 522, National Institute on Drug Abuse Grant No. K23DA037453, and AHRQ No. R01HS024270: (PACE).
: The authors declare that they have no conflicts of interest.
: This analysis was performed with deidentified patient data, so was deemed exempt from individual informed consent procedures by the Institutional Review Board at OHSU. Community clinics in our network have consented to the use of their data in this manner.